InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Update


VANCOUVER, British Columbia, Feb. 17, 2023 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced financial results for the second quarter of fiscal year 2023 which ended December 31, 2022.

Read the original:
InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Update

Related Posts